Gene-specific methylation patterns in mammals play a role in a variety of biological processes in the embryo and adult tissues. These patterns are established during embryo development by a process that involves genomewide demethylation in the morula and de novo methylation in the pregastrula. To elucidate the mechanism of demethylation in the early mouse embryo, we have iD,ected mouse zygotes with gene sequences that were methylated in vitro by Hpa II methylase and analyzed the methylation status of specific sites in blastocyst DNA. Because it had been propagated in Escherichia coli, the DNA used for these iDJections was also methylated at adenine residues in GATC sites. This allowed us to eliminate fully methylated, unintegrated DNA by Dpn I digestion and fully unmethylated, integrated DNA that underwent several rounds of replication by Mbo I digestion. The integrated, odginally i 'ected DNA strands were in a hemimethylated state and survived this treatment. The methylation status of Hpa H sites in these molecules was analyzed by Hpa II digestion of the genomic DNA isolated from blastocysts, followed by PCR amplification using appropriate primers. The results demonstrate that demethylation is achieved by an active mechanism and that specific sites in imprinted genes escape demethylation, maintaining a methylated state throughout preimplantation development.
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A growing body of experimental data suggests the involvement of gene-specific methylation in the control of gene expression in vertebrates. It is also becoming clear that gene-specific methylation patterns are reestablished during embryonic development. However, much has yet to be learned about the specific mechanisms involved in the formation of new methylation patterns in the embryo. Genomewide demethylation characterizes preimplantation embryonic development in the mouse, resulting in the general erasure of the gametic pattern of methylation (1, 2) . A large number of Hpa II and Hha I sites in single-copy genes were shown to be unmethylated in the morula and blastula, irrespective of their methylation status in sperm and oocytes (2) . However, not all CpG sites in the genome are subject to this wave of demethylation. A variety of repetitive sequences are partially methylated (3), and specific sites in imprinted genes appear to be methylated both in the morula and in the blastula (4, 5) . The mechanism of this selective demethylation remains obscure. One possible mechanism for the genomewide demethylation is based on the passive loss of methyl groups, occurring as a result of consecutive rounds of replication in the absence of concomitant maintenance methylation. This mechanism is quite unlikely, since high levels of DNA methylase have been observed in the very early embryo at the time when demethylation is taking place (6, 7) . However, a recent study locates these high levels of methylase in
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. the nucleus only after the eight-cell stage (8) . Here, we provide proof that the demethylation in the preimplantation embryo is mediated by an active mechanism. We show that specific sites in a parentally imprinted gene are protected and remain methylated throughout preimplantation development. That specific sites in imprinted genes escape the demethylation in the morula and are also subject to a site-specific protective mechanism strongly suggests that methylation plays a role in parental imprinting. Further understanding of these processes will shed light on the molecular mechanisms involved in genomic imprinting.
MATERIALS AND METHODS
Plasmids. Two plasmids were used for injection into mouse zygotes. The first plasmid harbored the 5' region of the human apolipoprotein A-I gene (APOAI). This construct includes the 2.8-kb HindIII fragment (the 5' part of APOA1) cloned in pUC19 (9) . The second plasmid includes the 3.1-kb EcoRI fragment from the upstream region of the mouse Igf2 gene which was cloned in pGEM-4 (obtained from R. Chaillet, Harvard Medical School). This upstream region of Igf2 has been shown to display allelic methylation (10) .
Preparation of Zygotes, Morulae, and Blastulae. Six-to eight-week-old (C57BL x BALB/c)F1 females were treated for superovulation by intraperitoneal injections of 5 units of pregnant-mare serum gonadotropin, followed by an injection of 5 units of human chorionic gonadotropin 48 hr later. Superovulated females mated overnight, and zygotes removed from the oviducts 20 hr after injection of chorionic gonadotropin were used for injection experiments. Morulae and blastocysts for the analysis ofmethylation ofendogenous genes were isolated as described (11) . Injection into Zygotes. Approximately 1 pl of DNA (10 ng/,ul) was injected into each zygote. The injected zygotes were grown in culture in M-16 (Sigma) and kept in 5% C02/95% air at 370C to obtain blastocysts.
Methylation Assay by PCR. DNA was extracted from sperm, oocytes, morulae, and blastocysts, digested with Hpa II, and subjected to PCR as described (11) . The PCR was carried out for 40 cycles of 1.5 min at 94°C, 1.5 min at 55°C, and 2 min at 720C. The PCR products were electrophoresed in 2% agarose gels, blotted, and hybridized to the appropriate 32P-labeled probes or visualized by ethidium bromide staining, as described in the figure legends. Under these conditions, the amount ofvisualized product is linear over a 50-fold range of DNA concentration and the degrees of modification can be reproducibly measured. Both positive and negative controls for Hpa II digestion were carried out by assaying known methylated or unmethylated sites. In addition, reactions without DNA were carried out with each set ofprimers. These data are not always shown in the figures.
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Proc. Natl. Acad. Sci. USA 90 (1993) 10559 RESULTS As a first step toward the elucidation of the mechanism by which the genome-wide demethylation in the preimplantation embryo is achieved, we set up an experiment to distinguish between a passive and an active mode of demethylation. Fertilized mouse eggs received injections of a construct whose endogenous counterpart has been shown to undergo demethylation in vivo at the morula stage. It was assumed that the exogenous sequence would then be recognized by the demethylation apparatus and undergo demethylation at relevant Hpa II sites. We took advantage of the fact that the injected plasmid DNA is methylated at GATC sites (E. coli dam methylation) to eliminate unintegrated DNA, which remained fully methylated, by digesting the DNA with Dpn I. After several rounds of replication, the integrated molecules were completely unmethylated and could, therefore, be removed by Mbo I digestion. Only DNA molecules which represented the original integrated DNA (hemimethylated at GATC sites) were expected to survive digestion by a combination of Dpn I and Mbo I (Fig. 1A) . To analyze the methylation status of a CCGG site at these original injected molecules, DNA digested with Dpn I and Mbo I was further treated with Hpa II and subjected to PCR analysis using primers that flanked the CCGG and GATC sites. A PCR product was expected following digestion with Mbo I, Dpn I, and Hpa II if the demethylation process was carried out by a passive mechanism and not if it was carried out by an active mechanism (Fig. 1B) .
Demonstration of Active Demethylation in the Preimplantadion Embryo. A single Hpa II site in the human apolipoprotein A-I gene (APOA1) promoter region undergoes demethylation at the eight-cell stage of transgenic embryos (11). In the experiment described in Fig. 2 , we used a construct carrying this human homologue. This DNA was methylated in vitro by the Hpa II methylase and injected into mouse zygotes. Subsequently, DNA obtained from blastulae which were developed in vitro from the injected zygotes was digested by Mbo I and Dpn I, or by a combination of Mbo I, Dpn I, and Hpa II, and subjected to PCR (Fig. 2) . Although we could generate a PCR product following digestion with Mbo I and Dpn I (MD), this integrated DNA was found to be sensitive to Hpa II digestion (MDH). These results were reproducible in repetitive injections. The results clearly prove that the integrated human APOAI promoter region was recognized P R I M E R S (11) , and injected into zygotes. The injected zygotes were grown in culture to obtain blastocysts, as described in Materials and Methods. DNA was extracted from 70 blastocysts and divided into three portions. One-third of the DNA served as an undigested control (uncut), the second third was digested with Mbo I and Dpn I (MD), and the rest was digested by Mbo I, Dpn I, and Hpa II (MDH). All digestions were at 10 units of enzyme per jg of DNA. After digestion, the DNA was subjected to PCR analysis using primers 1 (5'-ATGGACAATTGGCAACTGCC-3') and 2 (5'-TAAGCAGCCAGCTCTTGCA-3'), which flank the CCGG (H) and GATC (M, D) sites, and primers 3 (5'-TCACCTG-GCTGCAATGAGTG-3') and 4 (5'-CGTGAGAAACCTGCT-GCCTC-3'), to obtain a positive control (see scheme). and demethylated at this Hpa II site by an active mechanism rather than a passive one (see Fig.1B ).
Protection of Specific Sites in the Mouse lgf2 Imprinted Gene from Demethylation. DNA methylation associated with genomic imprinting was assumed to be established in the gametes and maintained through the preimplantation embryo. Two recent studies (4, 5) have examined the methylation patterns ofthree murine genes that have been shown to display allelic expression: Igf2 (12) , Igf2r (13), and H19 (14) . Modification of two sites in the differentially methylated region 2 of Igf2r may indeed originate from the gametes and be maintained throughout preimplantation development (4). The maintenance of the methylation status of these specific sites during early embryogenesis suggests that these sites may be protected and, in this way, escape active demethylation. To gain some insight into this apparent site specificity, we chose to study two Hpa II sites located upstream to a differentially methylated region of the Igf2 imprinted gene (5, 10) (see Fig.  3 ). The results of this analysis revealed that one locus (site 1) was methylated in both gametes and remained modified in the morula and blastula stages of embryo development. In contrast, site 2, which was methylated in sperm and not in the oocyte (Fig. 3) , underwent demethylation just prior to the blastula stage. Thus while site 2 behaved in a manner similar to other sites in endogenous genes (2), site 1 did not appear to be subject to demethylation during early embryogenesis. This is in accordance with the methylation status of other sites located in the vicinity of imprinted genes (4, 5) .
This specificity implies that a mechanism must exist by which specific sites are protected and thereby escape demethylation during the wave of demodification which takes place in the early embryo. To examine whether the tagging of specific sites to be protected from demethylation is taking place during gametogenesis or it can be acquired postfertilSi te 1 ization, we injected methylated cloned sequences containing sites 1 and 2 into mouse zygotes (Fig. 3) . DNA ofthe resulting blastulae was isolated and digested by Mbo I and Dpn I (MD), or by Mbo I, Dpn I, and Hpa II (MDH), and subjected to PCR. The results (Fig. 4) clearly demonstrate that Hpa II site 1 escaped demethylation whereas site 2 underwent substantial demodification in the same cells. The faint band observed in the MDH lane of site 2 may represent integration of several copies of the gene, some of which stay partially methylated. In any event, the results suggest that a site-specific protection mechanism exists in the early embryo and that it can be acquired after fertilization.
It could be argued that the methylated state of site 1 in the blastocyst results from de novo methylation which follows a brief event of demethylation in the very early embryo. To examine this possibility, we analyzed the methylation status of site 1 in blastula DNA following injection of the same construct used in the previous experiment, in its nonmethylated state, into zygotes. Blastula DNA was digested by Mbo I and Dpn I (MD) or by Mbo I, Dpn I, and Hpa II (MDH), and subjected to PCR. The results (Fig. 4) demonstrate that when this site was introduced unmethylated, it remained unmodified at least through the blastula stage, indicating that this specific site is not subject to de novo methylation at any preimplantation developmental stage. Therefore, the methylated state of site 1 observed in the blastula is inherited from the gametes avoiding the genomewide demethylation that is characteristic of the morula stage. DISCUSSION We have previously studied the Hpa II and Hha I sites in a variety of tissue-specific genes and found them to undergo, without exception, demethylation in the 8-to 16-cell stage of mouse embryo development. Several genes also undergo (10) . Sites 1 and 2 (indicated by arrows) are Hpa II sites for which the status of methylation has been established by PCR, as described in the legend to Fig. 2 , by using the primers 1 (5'-CCCCCACAGCAACCCTTACTTAC-3') and 2 (5'-GCCACTAGACTTTAGCCCTGTGC-3') to analyze site 1 and primers 4 (5'-GCAAGGATTGGGATCAGCACA-3') and 5 (5'-CAGCAATCACAACCTGTGGC-3') to analyze site 2. Primer 3 (5'-TGCTCTTCCTCATGC-CGTTGCTG-3') was used for the positive control (MDH), as described in Fig. 4 . DNA samples were divided into two parts and one portion was digested by Hpa II. Undigested and digested DNA samples were subjected to PCR. PCR products were electrophoresed in 2% agarose gels, stained with ethidium bromide, and photographed by the UVP (Ultraviolet Products, Cambridge, England) computerized system. Lanes: -, undigested DNA; +, Hpa II-digested DNA. Controls without DNA (-DNA) were run with each set of primers. (Fig. 3) cloned in pGEM4 was methylated in vitro by M.Hpa II methyltransferase as described (11) . The methylated DNA was tested for complete methylation by Hpa II digestion. The methylated construct was injected into zygotes. In parallel, a nonmethylated construct was injected into another group of zygotes. Zygotes were propagated in vitro to the blastocyst stage as described in the legend to Fig. 2 . DNA was extracted from blastocysts and digested with either Mbo I and Dpn I (MD) or a combination of Mbo I, Dpn I, and Hpa II (MDH). The digested DNA samples were subjected to PCR amplification using primers 1 and 2 for site 1 and primers 4 and 5 for site 2 (see legend to Fig. 3 ). As a control to ensure the existence of DNA in the MDH samples, primers 1 and 3 were used (mdh) to obtain the short fragment which lacks the Hpa II sites (see Fig. 3 ). For each pair of primers, a no-DNA control (C) was run in parallel. The experiment with injected unmethylated site 1 also serves as a control, demonstrating that the endogenous DNA was completely digested by Mbo I, thus ruling out the possibility that the PCR product observed with methylated site 1 reflects the amplified endogenous counterpart sequence that escaped Mbo I digestion. demethylation in meiotic cells during oocyte maturation (2) . That the demethylation that we have observed in the oocytes occurred at a stage when no replication takes place strongly indicates that this demodification occurred by an active process which is not dependent on DNA replication. In contrast, the genome-wide demethylation previously observed in the morula stage of development, when cells are actively proliferating, could have been attributed to a passive mechanism based on replication without concomitant methylation. In fact, demethylation of the Li repetitive sequences has been studied in the early embryo and demethylation was shown to be somewhat inhibited in the presence of the replication inhibitor aphidicolin (6) . This result suggests that demethylation takes place during S phase of the cell cycle; however, it does not prove that the mechanism for demethylation is passive. Here, we provide direct proof that the genome-wide loss of methyl groups in the early mouse embryo is achieved by an active mechanism. Since our experimental approach is based on the analysis of methylation status of injected DNA that has been integrated into the cell genome, our results do not rule out the possibility that this demethylation takes place during S phase. A possibility of a mechanism that combines one round of replication with active demethylation of the resulting hemimethylated DNA should also be considered in light of the recent discovery of an in vitro demethylation process that involves replacement of 5-methylcytosine with cytosine by excision repair of hemimethylated DNA (15) . We are neither in a position to state that all demethylations are active nor able to know what the proportion ofthese two possible mechanisms is, ifpassive demethylation exists.
One site in Igf2 (5) and two sites in Igf2r (4) are methylated in the gamete and are maintained methylated through the blastocyst stage. This suggests that these loci are specifically recognized, most likely by specific binding proteins that act to create a local change in conformation which might prevent demethylation. Initially, these proteins could interact with the methylated DNA from one of the gametes and serve as a signal for discriminating between the paternal and maternal alleles during embryo development. However, the fact that the experiments described here are based on injecting foreign DNA sequences into zygotes demonstrates that the protection factors are capable of recognizing the foreign sequences and act to protect specific sites from undergoing demethylation, much like their role with respect to endogenous imprinted sequences.
Experiments in which two murine strains were interbred allowed for distinction between the alleles by using polymorphic sites. Analysis of the methylation status of each allele separately revealed that the methylation found in the blastocysts was allele-specific (5). This observation suggests that the protection mechanism that we describe here is not only site-specific but also allele-specific. The allele specificity of the protection mechanism can be understood only if the alleles are already marked in the gametes. This mark may then serve as a signal for the protection mechanism. Consistent with this suggestion is the observation of two sites in the Igf2r gene which are methylated in the mature oocyte and unmethylated in the sperm. This allele-specific methylation is maintained throughout preimplantation embryo development (4, 5) . These sites could serve as a signal for allele-specific protection of other sites that come methylated from both parents or allelic de novo methylation of sites that come unmethylated from both gametes. The protection mechanism that we demonstrate here may serve to maintain the methylation status of these sites. However, it was surprising that the protection worked as well on exogenously injected DNA. It will be interesting to learn whether this specific recognition of imprinted sequences can only be observed in the zygote when the two alleles are physically separated, or whether it is also functional in early embryonic diploid cells. The elucidation of the molecular nature of the protecting factors, the nature ofthe sequence which is essential for their binding, and the stage of development in which they function awaits further investigation.
